Mechanism and Spectrum of Action
Lincosamides have a bacteriostatic type of action, though at high concentrations they can exert a bactericidal effect. Their mechanism of action is based on the inhibition of bacterial protein synthesis: the drugs bind to the 50S ribosomal subunit (making them similar to macrolides) and block peptide bond formation at the translocation stage.
The spectrum of antimicrobial activity includes:
- Gram-positive cocci: staphylococci (including penicillinase-producing and antibiotic-resistant strains), streptococci, and pneumococci.
- Gram-positive bacilli: diphtheria pathogen.
- Anaerobic flora: pathogens of gas gangrene (Clostridium perfringens), tetanus (Clostridium tetani), and Bacteroides fragilis.
- Atypical pathogens: mycoplasmas.
Pharmacokinetics and Clinical Application
Both drugs in the group are resistant to hydrochloric acid in the stomach. Their key pharmacokinetic feature is a pronounced tropism for bone tissue and joints, where they achieve high concentrations.
Lincosamides are used as second-line (reserve) antibiotics. Main indications for use:
- Bone and joint infections: osteomyelitis, suppurative arthritis.
- Respiratory tract and ENT infections: pneumonia, tonsillopharyngitis, otitis media.
- Skin and soft tissue infections: furunculosis, pyoderma.
- Intra-abdominal and pelvic infections: conditions in which anaerobic microflora play a leading role in pathogenesis.
Drug Characteristics: Lincomycin and Clindamycin
Lincomycin is a natural antibiotic produced by actinomycetes Streptomyces lincolnensis. Its absorption and bioavailability are significantly reduced when taken with food. Therefore, the drug is prescribed strictly 1 hour before meals (every 8 hours orally) or parenterally (every 12 hours). Topical application 2–3 times a day is also possible.
Clindamycin is a semisynthetic analogue that surpasses lincomycin in antimicrobial activity. Its main advantages are:
- High bioavailability (about 90%).
- Absorption does not depend on food intake.
- Duration of action is approximately 6 hours.
Clindamycin is the drug of choice for severe infections caused by anaerobes (especially Bacteroides) and mixed flora. In addition, it is effective against protozoa: the causative agent of Pneumocystis pneumonia, toxoplasma, and plasmodia. In specific treatment regimens, it is combined with quinine (for chloroquine-resistant falciparum malaria) or pyrimethamine (for toxoplasmosis).
Safety profile and adverse effects
The use of lincosamides may be accompanied by a number of adverse reactions. General side effects include dyspeptic disorders (nausea, vomiting, diarrhea, abdominal pain), allergic reactions, and hematotoxicity in the form of transient neutropenia and thrombocytopenia.
Pseudomembranous colitis is the most formidable specific complication of lincosamide therapy. It is a type of superinfection that occurs due to the suppression of normal intestinal microflora by the antibiotic.
Pathogenesis of the complication:
- Uncontrolled proliferation of Clostridium difficile occurs (a bacterium that is normally a component of the intestinal flora).
- The pathogen begins to actively produce cytotoxin.
- Cytotoxin damages the intestinal wall, causing mucosal ulceration.
Clinically, colitis manifests as severe diarrhea and fever. Detoxification therapy is used to treat this condition, and drugs active against C. difficile are prescribed: metronidazole is the first-line agent, with oral vancomycin as an alternative.
Briefly: answers to topical questions
How does the pharmacokinetics of clindamycin differ from lincomycin?
The pharmacokinetics of semisynthetic clindamycin favorably differs from natural lincomycin by higher bioavailability and the absence of food-dependent absorption. Lincomycin must be taken strictly 1 hour before meals, as food impairs its pharmacokinetic parameters.
| Characteristic | Lincomycin | Clindamycin |
|---|---|---|
| Bioavailability | Lower | Higher (~90%) |
| Effect of food | Food decreases absorption and bioavailability | Absorption does not depend on food intake |
What side effects do lincosamides cause?
Lincosamides cause side effects involving the gastrointestinal tract, blood, as well as allergic reactions.
Main adverse events include:
- Dyspeptic disorders — abdominal pain, nausea, vomiting, and diarrhea.
- Hematotoxicity — transient neutropenia and thrombocytopenia.
- Allergic reactions — general hypersensitivity manifestations.
- Pseudomembranous colitis — a specific complication in the form of a superinfection. Caused by uncontrolled proliferation of Clostridium difficile against the background of the death of competing microflora. Accompanied by intestinal mucosal ulceration, fever, and severe bloody diarrhea.
With which antibiotics do lincosamides exhibit cross-resistance?
Lincosamides exhibit cross-resistance with macrolides and group B streptogramins.
This phenomenon is known as the MLS phenotype (or MLSB phenotype) of resistance. It is caused by the constitutive production of a methylase enzyme, which modifies the drug target—the 50S subunit of the bacterial ribosome. As a result, bacteria acquire simultaneous resistance to all macrolides, lincosamides, and structurally distinct streptogramins. Co-administration of macrolides and lincosamides is irrational, as they compete for binding and promote the development of this cross-resistance.
The main pharmacokinetic feature of lincosamides is easy to remember by association: Lincosamides treat Bones (or Bones/Co- in Russian). They are the drugs of choice for osteomyelitis due to their unique ability to deposit in bone tissue.
Class and exam questions
Why are lincosamides classified as reserve antibiotics?
They are used as second-line drugs due to their specific spectrum of action and the risk of severe complications, primarily pseudomembranous colitis.
How does food intake affect the absorption of lincosamides?
Food significantly reduces the absorption and bioavailability of natural lincomycin, so it is taken an hour before meals. Food does not affect the absorption of semisynthetic clindamycin.
How to treat pseudomembranous colitis caused by clindamycin use?
The first-choice drug for treating this superinfection is metronidazole. Vancomycin (oral) is used as an alternative, and detoxification therapy is also mandatory.
What else to study on this topic
- Mechanisms of bacterial resistance development to lincosamides and cross-resistance with macrolides.
- Combination therapy regimens for tropical malaria and toxoplasmosis involving clindamycin.
- Pathogenesis of intestinal mucosa damage by Clostridium difficile cytotoxins.
- Features of lincosamide use in dental practice and maxillofacial surgery.
Master the entire topic in the «Pharmacology» course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Lincosamides" and 5,304 other pages on the subject
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 116 video lessons on the subject
Other topics in the section "Antibacterial Chemotherapeutic Agents"
Free video lessons: pharmacologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.